Drug intelligence / Profile preview

Shenhuang Ruangao

Development stage: Unknown
Lead developer: Hainan Bikai Pharmaceutical
Modality: Recombinant Proteins and Enzymes, Small Molecules
Administration: Topical

Overview

Shenhuang Ruangao (Emperor's Ointment) is a topical Traditional Chinese Medicine (TCM) product developed and manufactured by Hainan Bikai Pharmaceutical. The formulation is a combination of Ginseng (Panax ginseng) and Royal Jelly. It is indicated for the treatment of various skin conditions, including dermatitis, eczema, minor burns, and skin chapping. The therapeutic effects are attributed to the ginsenosides in ginseng, which promote cell proliferation and collagen synthesis, and the bioactive compounds in royal jelly, which provide antimicrobial and anti-inflammatory benefits. The product is approved and marketed in China for dermatological use.

Brand names: Emperor's Ointment参皇软膏
Other names: Shenhuang OintmentGinseng and Royal Jelly Ointment

Beyond the preview

Go deeper on Shenhuang Ruangao.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shenhuang Ruangao.

Explore the full profile